News articles for Cumberland Pharmaceuticals Inc.:
Friday, March 7, 2014
Tuesday, March 4, 2014
Monday, March 3, 2014
Cumberland Pharmaceuticals Acquires Vaprisol® from Astellas Pharma US, Inc.
NASHVILLE, Tenn., March 3, 2014 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) today announced the acquisition of Vaprisol(®) from Astellas Pharma US, Inc.
Vaprisol(®) is a patented, prescription brand indicated to raise serum sodium levels in hospitalized patients with hyponatremia. The product was developed and registered by Astellas and ... read more
Thursday, February 27, 2014
Tuesday, November 5, 2013
Cumberland Pharmaceuticals Reports Third Quarter Financial Results
NASHVILLE, Tenn., Nov. 5, 2013 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company focused on hospital acute care and gastroenterology, today announced third quarter 2013 financial results.
Net Revenue: For the three months ended September 30, 2013, net revenue was $6.5 million compared ... read more
Tuesday, October 29, 2013